MOR208 plus lenalidomide in r-r diffuse large B-cell lymphoma

Chemoimmunotherapy or BTK inhibition for patients with CLL

CLL14: A chemotherapy-free regimen of venetoclax plus obinutuzumab for CLL

Novel methods of drug testing and biopsy in India

Comment: Laparoscopic versus open resection for colorectal liver metastases

Comment: Chemotherapy for frail and elderly patients with advanced gastroesophageal cancer

ASCO 2019 and vision for cancer control

Guiding treatment decisions through the use of molecular profiling in breast cancer

Managing metastatic breast cancer and beyond using PARP inhibitors

Updates in metastatic and early-stage breast cancer

PARP inhibitors in metastatic breast cancer: Where are we now?

ADAPTCycle: Adjuvant personalised therapy comparing endocrine therapy plus ribociclib versus chemotherapy in early breast cancer